Steven Lo Net Worth

The estimated Net Worth of Steven Lo is at least $2.21 Milion dollars as of 6 June 2022. Mr Lo owns over 442 units of Zosano Pharma Corp stock worth over $7,371 and over the last 14 years he sold ZSAN stock worth over $1,443,599. In addition, he makes $756,275 as Sr. VP of Operations, Pres oraz CEO & Director at Zosano Pharma Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Lo ZSAN stock SEC Form 4 insiders trading

Mr has made over 20 trades of the Zosano Pharma Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 442 units of ZSAN stock worth $314 on 6 June 2022.

The largest trade he's ever made was exercising 585,416 units of Zosano Pharma Corp stock on 16 November 2015 worth over $1,797,227. On average, Mr trades about 40,257 units every 63 days since 2010. As of 6 June 2022 he still owns at least 13,163 units of Zosano Pharma Corp stock.

You can see the complete history of Mr Lo stock trades at the bottom of the page.

Mr. Steven Lo biography

Steven Lo is the Sr. VP of Operations, Pres, CEO & Director at Zosano Pharma Corp.

What is the salary of Mr Lo?

As the Sr. VP of Operations, Pres oraz CEO & Director of Zosano Pharma Corp, the total compensation of Mr Lo at Zosano Pharma Corp is $756,275. There are no executives at Zosano Pharma Corp getting paid more.

How old is Mr Lo?

Mr Lo is 54, he's been the Sr. VP of Operations, Pres oraz CEO & Director of Zosano Pharma Corp since . There are 3 older and 5 younger executives at Zosano Pharma Corp. The oldest executive at Zosano Pharma Corp is Dr. Donald J. Kellerman, 66, who is the VP of Clinical Devel. & Medical Affairs.

What's Mr Lo's mailing address?

Steven's mailing address filed with the SEC is C/O VAXART, INC., 170 HARBOR WAY, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Zosano Pharma Corp

Over the last 10 years, insiders at Zosano Pharma Corp have traded over $5,506,679 worth of Zosano Pharma Corp stock and bought 790,627 units worth $1,835,090 . The most active insiders traders include M James Barrett, Enterprise Associates 12, L... oraz Steve Elms. On average, Zosano Pharma Corp executives and independent directors trade stock every 60 days with the average trade being worth of $44,258. The most recent stock trade was executed by Christine Matthews on 6 June 2022, trading 82 units of ZSAN stock currently worth $58.

What does Zosano Pharma Corp do?

Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on developing products where rapid administration of approved molecules with established safety and efficacy profiles may provide substantial benefit to patients, in markets where patients remain underserved by existing therapies. The company's transdermal microneedle system technology consists of titanium microneedles coated with drug that are designed to enable rapid systemic administration of therapeutics to patients. Zosano's lead product candidate is Qtrypta™ (M207), which is a proprietary formulation of zolmitriptan designed to be delivered via its transdermal microneedle system technology, as an acute treatment for migraine.

Complete history of Mr Lo stock trades at Corcept Therapeutics Inc, Puma Biotechnology Inc, Zosano Pharma Corp oraz Vaxart Inc

Zosano Pharma Corp executives and stock owners

Zosano Pharma Corp executives and other stock owners filed with the SEC include:

• Steven Lo,
  Sr. VP of Operations, Pres, CEO & Director
• Dr. Donald J. Kellerman,
  VP of Clinical Devel. & Medical Affairs
• Kleanthis Xanthopoulos,
  Independent Director
• Kenneth Greathouse,
  Independent Director
• Steven Elms,
  Independent Director
• Joseph Hagan,
  Director
• Linda Grais,
  Director
• Thorsten von Stein,
  Chief Medical Officer
• Eric Scharin,
  Vice President - Technical Operations
• Dushyant Pathak,
  Senior Vice President - Business Development
• Christine Matthews,
  Chief Financial Officer, Principal Financial Officer
• Steven Lo,
  Chief Executive Officer, Director
• John Walker,
  Chairman of the Board
• Kristina Warga,
  VP & Corp. Controller
• Lu Liu,
  VP of Technical Operations
• Jeffrey L. Quillen,
  Sec.
• Hayley Lewis,
  Sr. VP of Operations
• Christine Matthews,
  Chief Financial Officer
• Capital Iv, Lp Aisling Capi...,
  
• Winnie Wing Kei Tso,
  Chief Financial Officer
• Georgia Erbez,
  Interim CFO
• Konstantinos Alataris,
  President
• M James Barrett,
  Director
• Enterprise Associates 12, L...,
  
• Troy Edward Wilson,
  Director
• Enterprise Associates 12, L...,
  
• Kathy M. Mc Gee,
  Director
• Capital Management, Llc Kaz...,
  
• Gregory David Kitchener,
  Chief Financial Officer
• Elaine Yang,
  Director
• Enterprise Associates 12, L...,
  
• Realty Trust Inc Bio Med Re...,
  
• Laxmi Peri,
  Sr. Vice President, Operations
• Hayley Lewis,
  See Remarks
• Steve Elms,
  Director
• Donald J Kellerman,
  VP, Clinical Dev & Med Affairs